Clinical Validation of a Diagnostic Test Which Measures the Endometrial Prostaglandins Liquid 24 Hours Before Embryo Transfer and That is Capable of Predicting a State of Endometrial Receptivity

Igenomix2 sites in 1 country120 target enrollmentFebruary 2015

ConditionsInfertility

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Infertility
Sponsor: Igenomix
Enrollment: 120
Locations: 2
Primary Endpoint: endometrial receptivity
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This clinical validation study is being carried out to validate the efficacy of a test measuring the clinical application of prostaglandins present in the endometrial fluid in patients, 24 hours before the embryonic transfer. This test is capable of predicting endometrial receptivity without the need of performing a biopsy.

Registry

clinicaltrials.gov

Start Date

February 2015

End Date

December 2017

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

Igenomix

Responsible Party

Principal Investigator

Carlos Simon

Dr. Carlos Simón

Igenomix

Eligibility Criteria

Inclusion Criteria

•Any IVF patient being treated for single or double embryo transfer
•BMI: 20 - 30
•Normal ovarian response (7 - 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral Follicle Count)
•Elective embryo transfer
•Normal uterine cavity
•Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with donated oocytes.

Exclusion Criteria

•Patients with recurrent miscarriages ( ≥ 2 biochemical miscarriages; ≥ 2 clinical miscarriage)
•Patients with severe male factor ( ≥ 2\*106 espermatozoides/ml).